These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1280 related articles for article (PubMed ID: 12764369)
21. Mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway. Fukazawa H; Noguchi K; Murakami Y; Uehara Y Mol Cancer Ther; 2002 Mar; 1(5):303-9. PubMed ID: 12489846 [TBL] [Abstract][Full Text] [Related]
22. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK. Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225 [TBL] [Abstract][Full Text] [Related]
23. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity. Bagli E; Stefaniotou M; Morbidelli L; Ziche M; Psillas K; Murphy C; Fotsis T Cancer Res; 2004 Nov; 64(21):7936-46. PubMed ID: 15520200 [TBL] [Abstract][Full Text] [Related]
24. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644 [TBL] [Abstract][Full Text] [Related]
25. C-terminal fragment of tetanus toxin heavy chain activates Akt and MEK/ERK signalling pathways in a Trk receptor-dependent manner in cultured cortical neurons. Gil C; Chaib-Oukadour I; Aguilera J Biochem J; 2003 Jul; 373(Pt 2):613-20. PubMed ID: 12710887 [TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways. Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789 [TBL] [Abstract][Full Text] [Related]
27. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma. Guenther MK; Graab U; Fulda S Cancer Lett; 2013 Sep; 337(2):200-9. PubMed ID: 23684925 [TBL] [Abstract][Full Text] [Related]
28. Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells. McCubrey JA; Steelman LS; Hoyle PE; Blalock WL; Weinstein-Oppenheimer C; Franklin RA; Cherwinski H; Bosch E; McMahon M Leukemia; 1998 Dec; 12(12):1903-29. PubMed ID: 9844921 [TBL] [Abstract][Full Text] [Related]
29. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts. Cao X; Kambe F; Moeller LC; Refetoff S; Seo H Mol Endocrinol; 2005 Jan; 19(1):102-12. PubMed ID: 15388791 [TBL] [Abstract][Full Text] [Related]
30. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. Martelli AM; Tazzari PL; Tabellini G; Bortul R; Billi AM; Manzoli L; Ruggeri A; Conte R; Cocco L Leukemia; 2003 Sep; 17(9):1794-805. PubMed ID: 12970779 [TBL] [Abstract][Full Text] [Related]
31. Growth factor-stimulated phosphorylation of Akt and p70(S6K) is differentially inhibited by LY294002 and Wortmannin. Adi S; Wu NY; Rosenthal SM Endocrinology; 2001 Jan; 142(1):498-501. PubMed ID: 11145615 [TBL] [Abstract][Full Text] [Related]
32. Oncogenic Raf-1 activates p70 S6 kinase via a mitogen-activated protein kinase-independent pathway. Lenormand P; McMahon M; Pouysségur J J Biol Chem; 1996 Jun; 271(26):15762-8. PubMed ID: 8663120 [TBL] [Abstract][Full Text] [Related]
33. Extracellular ATP-induced proliferation of adventitial fibroblasts requires phosphoinositide 3-kinase, Akt, mammalian target of rapamycin, and p70 S6 kinase signaling pathways. Gerasimovskaya EV; Tucker DA; Weiser-Evans M; Wenzlau JM; Klemm DJ; Banks M; Stenmark KR J Biol Chem; 2005 Jan; 280(3):1838-48. PubMed ID: 15522879 [TBL] [Abstract][Full Text] [Related]
34. In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein. Mehrhof FB; Müller FU; Bergmann MW; Li P; Wang Y; Schmitz W; Dietz R; von Harsdorf R Circulation; 2001 Oct; 104(17):2088-94. PubMed ID: 11673351 [TBL] [Abstract][Full Text] [Related]
35. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling. Wang Z; Jiang C; Ganther H; Lü J Cancer Res; 2001 Oct; 61(19):7171-8. PubMed ID: 11585751 [TBL] [Abstract][Full Text] [Related]
36. The cell survival signal Akt is differentially activated by PDGF-BB, EGF, and FGF-2 in osteoblastic cells. Chaudhary LR; Hruska KA J Cell Biochem; 2001 Mar; 81(2):304-11. PubMed ID: 11241670 [TBL] [Abstract][Full Text] [Related]
37. Effects of a conditionally active v-ErbB and an EGF-R inhibitor on transformation of NIH-3T3 cells and abrogation of cytokine dependency of hematopoietic cells. McCubrey JA; Shelton JG; Steelman LS; Franklin RA; Sreevalsan T; McMahon M Oncogene; 2004 Oct; 23(47):7810-20. PubMed ID: 15361836 [TBL] [Abstract][Full Text] [Related]
38. Rapamycin and UCN-01 synergistically induce apoptosis in human leukemia cells through a process that is regulated by the Raf-1/MEK/ERK, Akt, and JNK signal transduction pathways. Hahn M; Li W; Yu C; Rahmani M; Dent P; Grant S Mol Cancer Ther; 2005 Mar; 4(3):457-70. PubMed ID: 15767555 [TBL] [Abstract][Full Text] [Related]
39. Differential activation of protein kinase B and p70(S6)K by glucose and insulin-like growth factor 1 in pancreatic beta-cells (INS-1). Dickson LM; Lingohr MK; McCuaig J; Hugl SR; Snow L; Kahn BB; Myers MG; Rhodes CJ J Biol Chem; 2001 Jun; 276(24):21110-20. PubMed ID: 11274216 [TBL] [Abstract][Full Text] [Related]
40. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism. Romerio F; Riva A; Zella D Br J Cancer; 2000 Aug; 83(4):532-8. PubMed ID: 10945503 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]